Abstract
As a part of our continuing investigation of the manzamine alkaloids we studied the in vitro activity of the β-carboline containing manzamine alkaloids against Fusarium solani, Fusarium oxysporium, and Fusarium proliferatum by employing several bioassay techniques including one-dimensional direct bioautography, dilution, and plate susceptibility, and microtiter broth assays. In addition, we also studied the metabolism of the manzamine alkaloids by Fusarium spp. in order to facilitate the redesign of the compounds to prevent resistance of Fusarium spp. through metabolism. The present research reveals that the manzamine alkaloids are inactive against Fusarium spp. and the fungi transform manzamines via hydrolysis, reduction, and a retro Pictet-Spengler reaction. This is the first report to demonstrate an enzymatically retro Pictet-Spengler reaction. The results of this study reveal the utility of the rational design of metabolically stable antifungal agents from this class and the development of manzamine alkaloids as antimalarial drugs through the utilization of Fusarium’s metabolic products to reconstruct the molecule.
Similar content being viewed by others
References
Abraham WR, Spassov G (2002) Biotransformation of alkaloids: a challenge. Heterocycles 56:711–741
Agrios GN (1988) Plant pathology, 3rd edn. Academic, New York, pp 408–409
Ang KK, Holmes MJ, Higa T, Hamann MT, Kara UA (2000) In vivo antimalarial activity of beta-carboline alkaloid manzamine A. Antimicrob Agent Chemother 44:1645–1649
Arikan S, Lozano-Chiu M, Paetznik V, Rex JH (2002) In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother 46:245–247
Bryden LW, Logrieco A, Abbas KH, Porter JK, Vesonder RF, Richard JL, Cole RJ (2001) Other significant fusarium mycotoxin. Fusarium Summerell BA, Leslie FJ, Backhouse D, Bryden WL, Burgess LW (ed) American Phytopathological Society: 360
Canuto MM, Rodero FG (2002) Antifungal drug resistance to azoles and polyenes. Lancet Infect Dis 2:550–563
Cao R, Peng W, Wang Z, Xu A (2007) β-Carboline alkaloids: biochemical and pharmacological functions. Curr Med Chem 14:479–500
Edrada RA, Prosksch V, Wray V, Witte L, Müeller WEG, Van Soest RWM (1996) Four new bioactive manzamine-type alkaloids from the Philippine marine sponge Xestospongia ashmorica. J Nat Prod 59:1056–1060
El Sayed KA, Dunbar CD, Perry TL, Wilkins SP, Hamann MT, Greenplate JT, Wideman MA (1997) Marine natural products as prototypes of insecticidal agents. J Agric Food Chem 45:2735–2739
Guarro J, Gene J (1995) Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 14:741–754
Hamann MT, Alonso D, Martin-Aparacio E, Fuertes A, Perez-Puerto JM, Castro A, Morales S, Navarro ML, del Monte-Millán M, Medina M, Pennaka H, Balaiah A, Peng J, Cook J, Wahyuono S, Martinez A (2007) GSK-3 Inhibitory activity and SAR studies of the manzamine alkaloids. Potential for Alzheimer’s disease. J Nat Prod 70:1397–1405
Hu JF, Hamann MT, Hill RT, Kelly M (2003) The manzamine alkaloids. In: Cordell GA (ed) The alkaloids, vol 60. Elsevier, New York, pp 207–285
Ichiba T, Sakai R, Kohmoto S, Saucy G, Higa T (1988) New manzamine alkaloids from a sponge of the genus Xestospongia. Tetrahedron Lett 29:3083–3086
Kasanah N, Hamann MT (2005) Evaluation of SPK-843. Curr Opin Investig Drugs 6:845–853
Kasanah N, Rao KV, Yousaf M, Wedge D, Hamann MT (2003) Biocatalytic conversion of 8-hydroxymanzamine A to manzamine A. Tetrahedron Lett 44:1291–1293
Kasanah N, Rao KV, Yousaf M, Wedge DE, Hill RT, Hamann MT (2004) Biotransformation studies of the manzamine alkaloid. Mar Biotech 6:S268–S272
Kobayashi J, Tsuda M, Kawasaki N, Sasaki T, Mikami Y (1994) 6-hydroxymanzamine A and 3,4-dihydromanzamine A, new alkaloids from the Okinawan marine sponge Amphimedon sp. J Nat Prod 57:1737–1741
Kondo K, Shigemori H, Kikuchi Y, Ishibashi M, Sasaki T, Kobayashi J (1992) Ircinals A and B from Okinawan marine sponge Ircinia sp: plausible biogenetic precursor of manzamine alkaloids. J Org Chem 57:2480–2483
Kontoyiannis DM, Lewis RE (2002) Antifungal drug resistance of pathogenic fungi. Lancet 359:1135–1144
Lewis RE, Wiederhold NP, Klepser ME (2005) In vitro pharmacodynamics of amphotericin B, itraconazole and voriconazole against Aspergillus, Fusarium and Scedosporium spp. Antimicrob Agents Chemother 49:945–951
Li H-Y, Matsunaga S, Fusetani N (1998) Antifungal metabolites from sponges. Curr Org Chem 2:649–682
Lionakis MS, Lewis RE, Samonis G, Kontoyianis DP (2003) Pentamidine is active against Fusarium species. Antimicrob Agents Chemother 47:3252–32
Loeffler J, Stevens DA (2003) Antifungal drug resistance. Clin Infect Dis 36(Suppl):S31–S41
Mayer AMS, Gunasakera SP, Pomponi SA, Sennett SH (2000) Antiinflammatory uses of manzamines. PCT Int Appl, CODEN: PIXXD2 WO 0056304A220000928
Molinski TF (2004) Antifungal compounds from marine organisms. Curr Med Chem Anti-infective Agents 3:197–220
Morrissey JP, Osbourn AE (1999) Fungal resistance to plant antibiotics as a mechanism of pathogenesis. Microbiol Mol Biol Rev 63:708–724
Nielsen TE, Dines F, Morten M (2003) The Pictet-Spengler reaction in solid phase combinatorial chemistry. Curr Opin Drug Disc Dev 6:801–814
Peng J, Shen X, El Sayed KA, Dunbar DC, Perry TL, Wilkins SP, Hamann MT, Bobzin S, Huesing J, Camp R, Prinsen M, Krupa D, Wideman MA (2003) Marine natural products as prototype agrochemical agents. J Agric Food Chem 51:2246–2252
Perea S, Patterson TF (2002) Antifungal resistance in pathogenic fungi. Clin Infect Dis 35:1073–1080
Rao KV, Santarsiero BD, Mesecar AD, Schinazi RF, Tekwani BL, Hamann MT (2003) New manzamine alkaloids with activity against infectious and tropical parasitic diseases from Indonesian sponges. J Nat Prod 66:823–827
Rao KV, Kasanah N, Wahyuono S, Tekwani BL, Schinazi RF, Hamann MT (2004) Three new manzamine alkaloids from common Indonesian sponges and their activity against infectious and tropical parasitic diseases. J Nat Prod 67:1314–1318
Rathbone DA, Bruce NC (2002) Microbial transformation of alkaloids. Curr Opin Microbiol 5:274–281
Turbek CS, Li DX, Choi GH, Schardl CL, Smith DA (1992) An extracellular enzyme from Fusarium solani f sp. phaseoli which catalyze hydration of the isoflavonoid phytoalexin, phaseollidin. FEMS Microbiol Lett 94:187–190
VanEtten HD, Matthews DE, Matthews PS (1989) Phytoalexin detoxification: importance for pathogenicity and practical implications. Ann Rev Phytopathol 27:143–164
Wedge DE, Nagle DG (2000) A New 2D TLC bioautography method for the discovery of novel antifungal agents to control plant pathogens. J Nat Prod 63:1050–1054
White TC, Marr KA, Bowden RA (1998) Clinical, cellular and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 11:382–402
Yousaf M, El Sayed KA, Rao KV, Lim CW, Hu JF, Kelly M, Franzblau F, Peraud O, Hill RT, Hamann MT (2002) 12,34 Oxamanzamine, novel biocatalytic and natural products from manzamine Indo-Pacific producing sponges. Tetrahedron 59:7397–7402
Yousaf M, Hammond NL, Peng JP, Wahyuono S, McIntosh KA, Charman WN, Mayer AMS, Hamann MT (2004) New manzamine alkaloids from an Indo-Pacific sponge: pharmacokinetics, oral availability and the significant activity of several manzamine against HIV-1, AIDS opportunistic infections and inflammatory diseases. J Med Chem 47:3512–3517
Yue Q, Bacon CW, Richardson MD (1998) Biotransformation of 2-benzoxazolinone and 6-methoxybenzoxazolinone by Fusarium moniliforme. Phytochem 48:451–454
Zhang Y, Smith DA (1983) Concurrent metabolism of phytoalexins phaseollin, kievitone and phaseollinisoflavan by Fusarium solani f.sp. phaseoli. Physiol Plant Pathol 23:89–100
Zhang LH, Gupta AK, Cook JM (1989) Reinvestigation of mechanism of the acid catalyzed epimerization of reserpine to isoreserpine. J Org Chem 54:4708–4712
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kasanah, N., Farr, L.L., Gholipour, A. et al. Metabolism and Resistance of Fusarium spp. to the Manzamine Alkaloids via a Putative Retro Pictet-Spengler Reaction and Utility of the Rational Design of Antimalarial and Antifungal Agents. Mar Biotechnol 16, 412–422 (2014). https://doi.org/10.1007/s10126-014-9557-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10126-014-9557-0